Injection Sclerotherapy With Bleomycin VS Doxycycline in Patients With Lymphatic Malformations

Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age0-12
SponsorBasharat Hussain

About this trial

This is a randomized clinical trial comparing the safety and effectiveness of injection sclerotherapy using bleomycin versus doxycycline in children under 12 years with lymphatic malformations. The study will assess reduction in lesion size, clinical improvement, and treatment-related complications over six months.

Eligibility criteria

Qualifiers

None

Disqualifiers

microcytic lymphatic malformations Allergies to bleomycin/Doxycycline. Significant co morbidities Active infection at lesion site.

Trial design

Treatments tested in this trial

  • Bleomycin
  • doxycycline (tetracycline)

Treatment groups

92 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Basharat Hussain

Lead sponsor

Holy Family Hospital, Pakistan

Sponsor institution